In the beginningWas the word...and the word is getting out.
IZO ) (OTC: IZOZF ) (FSE: 1R3 ) (CNSX:IZO.CN) , a company developing high-resolution 3D dedicated breast CT imaging technology for the earlier detection and diagnosis of breast cancers, announces is has begun USA focused marketing awareness aimed at maintaining and building the profile of IZOZF through press initiatives, advertising, and social media strategies.
As part of these marketing plans, Izotropic has engaged with ThinkInk Marketing Inc., an arm's-length party to the company, to provide a 12-month digital advertising campaign designed to build recognition within online investor content platforms. Izotropic has allocated USD $250,000 to its scalable advertising budget. ThinkInk Marketing Inc. has no present interest, directly or indirectly, in Izotropic or its securities.
Izotropic has also ramped up the content flow on social media channels and is pleased to report an over 200% increase in traffic to its website in the past month and positive engagement from new investors through email drip campaign activities.